
AI / Quality / Training
AI-based SOP knowledge assistant
An assistant that answers procedural questions from effective SOPs, with citations.
Illustrative use caseCapability
Practical AI where it helps pharmaceutical work — research, development, manufacturing, quality, regulatory, laboratory and supply chain — governed from day one.


AI earns its place in pharmaceutical work when it reduces review effort, surfaces patterns people miss, or makes knowledge easier to find — and when a qualified person still owns the decision.
We identify use cases, assess data readiness and risk, design the human-in-the-loop controls, and build or configure the solution with the validation evidence your quality unit needs.
Each activity shows who performs it. We do not claim facilities we do not own.
DGXP-led Led by the DGXPComplianceLab team Partner-coordinated Performed by a qualified partner, coordinated by us
Workshops to find where AI adds measurable value.
Data sources, quality, access and integrity.
Model approach, retrieval design and human oversight.
Assistants, analytics and document intelligence tools.
Fit-for-intended-use testing and performance criteria.
Performance, drift and change control after go-live.
Select an area to see where AI can reasonably help today.
Every use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.
How we govern AIEvery use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.
How we govern AIEvery use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.
How we govern AIEvery use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.
How we govern AIEvery use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.
How we govern AIEvery use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.
How we govern AIEvery use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.
How we govern AIEvery use case starts with an intended use and a risk assessment. Outputs support a qualified person; they do not replace the decision.
How we govern AIIllustrative use cases showing how this capability is typically applied.

AI / Quality / Training
An assistant that answers procedural questions from effective SOPs, with citations.
Illustrative use case
AI / Regulatory
Using AI to locate, compare and summarise content across regulatory documents.
Illustrative use case
AI / Quality / Manufacturing
Surfacing similar past deviations and likely contributing factors to support investigators.
Illustrative use case
AI / Quality
Classifying proposed AI use cases by risk and defining the validation each one needs.
Illustrative use caseEvery engagement follows the same eight steps, scaled to the size and risk of the project.
Understand business and technical requirements.
Assess scientific, technical, regulatory and operational requirements.
Design the appropriate solution.
Identify appropriate internal and external capabilities and partners.
Coordinate and execute the project.
Test, verify, qualify or validate where applicable.
Create technical, quality and regulatory documentation.
Monitor, optimise and continuously improve.
AI is not implemented simply because it is available. In pharmaceutical work it needs an intended use, a risk assessmen…
Converting paper-based and fragmented pharmaceutical processes into controlled, connected digital workflows that stay c…
Software designed around pharmaceutical workflows — requirements, workflow design, validation and documentation include…
In our approach AI assists; a qualified person reviews and decides. The level of oversight is set by risk assessment.
Deployment options and data flows are decided during design. Confidentiality and data-residency requirements are captured as requirements.
Through acceptance criteria defined before testing, validation against representative data, and ongoing performance monitoring.
Share the product, stage and timeline. Capability is confirmed after technical assessment and partner availability.